The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Trends in cancer incidence and mortality in Scotland: description and possible explanations
Open accessAbstract
Secular and cohort trends in mortality from cancer in Scotland during 1953-93, and incidence during 1960-90, were analysed using individual records from the national mortality and registration files. For certain cancer sites, the secular analyses of mortality were extended back to 1911 by use of published data. Mortality from cancer at older ages in Scotland has increased over the last 40 years. In each sex, this trend has been dominated by the effects of smoking: all-cancer rates and rates of lung cancer, now the most common fatal cancer in men and in women in Scotland, reached a peak in the cohort of men born at the turn of the century and the cohort of women born in the 1920s. For much of the period, the Scottish all-age rates of lung cancer were the highest reported in the world; they are now decreasing on a secular basis in men, but are still increasing in women. There have also been large increases at older ages in the incidence and mortality rates for cancer of the prostate in recent years. bladder cancer, nervous system cancer, non-Hodgkin's lymphoma, myeloma and leukaemia; for each there is likely to be a considerable artefactual element to the increase, with differing degrees of possibility that there may in addition be an element of real increase. Substantial decreases in mortality at all ages have occurred for stomach and colorectal cancers and substantial increases at all ages for pleural cancer and melanoma. Rates of mortality from breast cancer, the most common cancer in women in Scotland, have generally increased over the past 80 years; a temporary cessation in this upward trend occurred in the years during and after the Second World War, and recently rates have turned downward, probably at least in part because of better treatment. Mortality from ovarian cancer, the second most common reproductive-related female tumour in Scotland, has also increased at older ages. At younger ages, mortality from cancer in Scotland has decreased, especially in men, whereas incidence has not. This divergence, which has been a consequence of better treatment, has occurred especially for cancers of the testis and ovary, Hodgkin's disease and leukaemia. There have been increases at young adult ages, however, in both mortality from and incidence of oral and pharyngeal, oesophageal and laryngeal cancers in men, and melanoma and non-Hodgkin's lymphoma in each sex. Cervical cancer rates at young ages also increased, but this trend has reversed for incidence in the most recent birth cohorts. Incidence rates have also increased for testicular cancer in young adults and leukaemia in children. With the possible exceptions of non-Hodgkin's lymphoma and childhood leukaemia, the increasing rates are likely largely to reflect real rises in incidence, and they highlight the need for investigation of the causes of these cancers, and, when causes are known, for preventive action.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rising incidence of adenocarcinoma of the esophagus and gastric cardia
Blot, W. J. (1991) · JAMA · doi:10.1001/jama.265.10.1287 · Cited by 2,354
Are oestrogens involved in falling sperm counts and disorders of the male reproductive tract?
Sharpe, R. M., & Skakkebaek, N. E. (1993) · The Lancet · doi:10.1016/0140-6736(93)90953-e · Cited by 1,849
Continuing increase in mesothelioma mortality in Britain
Peto, J., Matthews, F. E., Hodgson, J. T., & Jones, J. R. (1995) · The Lancet · doi:10.1016/s0140-6736(95)90462-x · Cited by 568
The Cohort Effect and Helicobacter pylori
Banatvala, N., Mayo, K., Megraud, F., Jennings, R., Deeks, J. J., & Feldman, R. A. (1993) · The Journal of Infectious Diseases · doi:10.1093/infdis/168.1.219 · Cited by 539
Increase in Testicular Cancer Incidence in Six European Countries: a Birth Cohort Phenomenon
Bergström, R., Adami, H.-O., Möhner, M., Zatonski, W., Storm, H., Ekbom, A., Tretli, S., Teppo, L., Akre, O., & Hakulinen, T. (1996) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/88.11.727 · Cited by 439
Non-Hodgkin's lymphoma time trends: United States and international data.
Devesa, S. S., & Fears, T. R. (1992) · PubMed · Cited by 355
CANCER OF THE CERVIX: A SEXUALLY TRANSMITTED INFECTION?
Beral, V. (1974) · The Lancet · doi:10.1016/s0140-6736(74)90432-2 · Cited by 317
A prospective study of 1152 hospital autopsies: I. Inaccuracies in death certification
Cameron, H. M., & McGoogan, E. (1981) · The Journal of Pathology · doi:10.1002/path.1711330402 · Cited by 303
Rise in prostatic Cancer Incidence Associated With Increased Use of Transurethral Resection
Potosky, A. L., Kessier, L., Gridley, G., Brown, C., & Horm, J. W. (1990) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/82.20.1624 · Cited by 166
Cameron, H. M., & McGoogan, E. (1981) · The Journal of Pathology · doi:10.1002/path.1711330403 · Cited by 146
Cited by
Guidelines for the welfare and use of animals in cancer research
An ad hoc committee of the National Cancer Research Institute, Workman, P., Aboagye, E. O., Balkwill, F., Balmain, A., Bruder, G., Chaplin, D. J., Double, J. A., Everitt, J., Farningham, D. A. H., et al. (2010) · British Journal of Cancer · doi:10.1038/sj.bjc.6605642 · Cited by 1,442
Zeisberger, S. M., Odermatt, B., Marty, C., Zehnder-Fjällman, A. H. M., Ballmer-Hofer, K., & Schwendener, R. A. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603240 · Cited by 623
Increasing Incidence of Testicular Cancer Worldwide: A Review
HUYGHE, E., MATSUDA, T., & THONNEAU, P. (2003) · Journal of Urology · doi:10.1097/01.ju.0000053866.68623.da · Cited by 605
Aird, R. E., Cummings, J., Ritchie, A. A., Muir, M., Morris, R. E., Chen, H., Sadler, P. J., & Jodrell, D. I. (2002) · British Journal of Cancer · doi:10.1038/sj.bjc.6600290 · Cited by 582
Tumor Ablation with Irreversible Electroporation
Al-Sakere, B., André, F., Bernat, C., Connault, E., Opolon, P., Davalos, R. V., Rubinsky, B., & Mir, L. M. (2007) · PLoS ONE · doi:10.1371/journal.pone.0001135 · Cited by 490
Brough, P. A., Aherne, W., Barril, X., Borgognoni, J., Boxall, K., Cansfield, J. E., Cheung, K.-M. J., Collins, I., Davies, N. G. M., Drysdale, M. J., et al. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm701018h · Cited by 444
Wei, L., Lee, D., Law, C.-T., Zhang, M. S., Shen, J., Chin, D. W.-C., Zhang, A., Tsang, F. H.-C., Wong, C. L.-S., Ng, I. O.-L., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-12606-7 · Cited by 428
Horwich, A., Shipley, J., & Huddart, R. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68305-0 · Cited by 398
McClue, S. J., Blake, D., Clarke, R., Cowan, A., Cummings, L., Fischer, P. M., MacKenzie, M., Melville, J., Stewart, K., Wang, S., et al. (2002) · International Journal of Cancer · doi:10.1002/ijc.10738 · Cited by 364
Marczylo, T. H., Verschoyle, R. D., Cooke, D. N., Morazzoni, P., Steward, W. P., & Gescher, A. J. (2007) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-006-0355-x · Cited by 360
The global burden of urinary bladder cancer
Parkin, D. M. (2008) · Scandinavian Journal of Urology and Nephrology · doi:10.1080/03008880802285032 · Cited by 357
Role of cytokines in photodynamic therapy-induced local and systemic inflammation
Gollnick, S. O., Evans, S. S., Baumann, H., Owczarczak, B., Maier, P., Vaughan, L., Wang, W. C., Unger, E., & Henderson, B. W. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6600864 · Cited by 348
Perera, T. P. S., Jovcheva, E., Mevellec, L., Vialard, J., De Lange, D., Verhulst, T., Paulussen, C., Van De Ven, K., King, P., Freyne, E., et al. (2017) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-16-0589 · Cited by 334
Li, L., Ahmed, B., Mehta, K., & Kurzrock, R. (2007) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0556 · Cited by 332
Qiao, L., Xu, Z.-L., Zhao, T.-J., Ye, L.-H., & Zhang, X.-D. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.04.032 · Cited by 313
Gowan, S. M., Harrison, J. R., Patterson, L., Valenti, M., Read, M. A., Neidle, S., & Kelland, L. R. (2002) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)12212-2 · Cited by 303
Dredge, K., Marriott, J. B., Macdonald, C. D., Man, H.-W., Chen, R., Muller, G. W., Stirling, D., & Dalgleish, A. G. (2002) · British Journal of Cancer · doi:10.1038/sj.bjc.6600607 · Cited by 296
Raynaud, F. I., Eccles, S. A., Patel, S., Alix, S., Box, G., Chuckowree, I., Folkes, A., Gowan, S., De Haven Brandon, A., Di Stefano, F., et al. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-1200 · Cited by 271
Dredge, K., Horsfall, R., Robinson, S. P., Zhang, L.-H., Lu, L., Tang, Y., Shirley, M. A., Muller, G., Schafer, P., Stirling, D., et al. (2005) · Microvascular Research · doi:10.1016/j.mvr.2005.01.002 · Cited by 268
Role of glucose and ketone bodies in the metabolic control of experimental brain cancer
Seyfried, T. N., Sanderson, T. M., El-Abbadi, M. M., McGowan, R., & Mukherjee, P. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6601269 · Cited by 267
Novel Temperature-Sensitive Liposomes with Prolonged Circulation Time
Lindner, L. H., Eichhorn, M. E., Eibl, H., Teichert, N., Schmitt-Sody, M., Issels, R. D., & Dellian, M. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0035 · Cited by 258
Leenaars, M., & Hendriksen, C. F. M. (2005) · ILAR Journal · doi:10.1093/ilar.46.3.269 · Cited by 253
Eley, H. L., Russell, S. T., Baxter, J. H., Mukerji, P., & Tisdale, M. J. (2007) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00314.2007 · Cited by 204
A systematic approach for establishing humane endpoints
Morton, D. B. (2000) · ILAR Journal · doi:10.1093/ilar.41.2.80 · Cited by 193
Effect of Branched-Chain Amino Acids on Muscle Atrophy in Cancer Cachexia
Eley, H. L., Russell, S. T., & Tisdale, M. J. (2007) · Biochemical Journal · doi:10.1042/bj20070651 · Cited by 184
Connolly, K., Mitter, R., Muir, M., Jodrell, D., & Guichard, S. (2009) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-008-0872-x · Cited by 34
Metadata
- Authors
- Swerdlow, A., dos Santos Silva, I., Reid, A., Qiao, Z., Brewster, D., & Arrundale, J.
- Venue
- British Journal of Cancer
- Published
- 1998-01
- Volume
- 77
- Issue
- S3
- Pages
- 1-16
- ISSN
- 0007-0920 (ISSN-L)
- 1532-1827
- OpenAlex
- W2030288839
- Cited by
- 532
- References
- 23
- FWCI
- 6.05
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.